HOME >> MEDICINE >> NEWS
SNM collaboration yields diagnostic nuclear medicine guide for compliance with NRC regulations

Reston, VA....The Society of Nuclear Medicine (SNM) announced today the release of a unique, one-stop reference work for diagnostic nuclear medicine professionals who want to bring their departments and institutions into compliance with recently revised federal regulations governing the medical use of byproduct material. Guide for Diagnostic Nuclear Medicine, published by the SNM and authored by Jeffry A. Siegel, PhD, represents the first major joint effort between the Nuclear Regulatory Commission (NRC; Bethesda, MD) and a stakeholder organization whose members' professional practices are regulated by NRC rules.

The new NRC regulations under 10 CFR Part 35 (Medical Use of Byproduct Material) became effective October 24, 2002, and govern the medical use and licensing of byproduct materials across the spectrum of diagnostic practice. The revised rule is intended to be less prescriptive than the current rule. The most significant change, according to Siegel, is "a new emphasis on risk-informed, performance-based approaches that focus not on procedures but on outcomes." Since the first use of nuclear medicine in the United States in the 1940s, more than one-third of a billion doses have been administered to patients, with unparalleled safety and almost no adverse events. In structuring the new regulations, the NRC took this low risk into account by eliminating or decreasing the prescriptiveness of the regulations that apply to diagnostic nuclear medicine. Instead, the NRC is relying on a performance-based approach that emphasizes not a step-by-step adherence to "best practices" but a consistent level of performance outcomes by institutions at which nuclear medicine is practiced.

"With this changed focus, we knew that it would be useful for practitioners to have a stand-alone document that suggests appropriate operating policies and sample procedures for compliance with the revised Part 35 and with other NRC regulations," says Siegel, who is chair of t
'"/>

Contact: Becky Haines
Bhaines@snm.org
703-708-9000
Society of Nuclear Medicine
30-Oct-2002


Page: 1 2 3

Related medicine news :

1. Houston meeting kicks off collaboration to advance cancer research
2. Novartis announces collaboration with Bayer for EMSELEX
3. Call for national collaboration on medical education research
4. Former President George Bush joins leaders from cancer community to announce historic collaboration
5. University of Pittsburgh and French National Institute begin scientific collaboration
6. Nordic collaboration gives new insights into adjuvant chemotherapy
7. UCSD-TCAG collaboration to focus on transformation of genome-based knowledge into health benefits
8. $15 million grant spurs cancer collaboration; M. D. Anderson, University of Puerto Rico
9. UNC Center for AIDS Research database collaboration with SAS also helping patient care
10. NIH-funded UCSD rheumatic diseases center to facilitate collaboration, speed discoveries
11. New rapid anthrax test developed through collaboration between Mayo Clinic and Roche Diagnostics. Test, which provides results in less than one hour, will be made available to United States laboratories

Post Your Comments:
(Date:3/30/2015)... Vancouver personal injury lawyer firm, Jiwa Law ... taken up by the firm are settled before they ... protect the interests of their clients without them having ... comes across as an achievement for the personal injury ... to their client, without compromising their rights. , ...
(Date:3/30/2015)... This report studies the global tumor ablation market ... , Based on the type of technology, the ... major segments, namely radio-frequency, microwave, cryoablation and other ... ablation) segments. Moreover, based on type of departments, ... three segments, namely, interventional radiology, surgery and oncology. ...
(Date:3/30/2015)... 30, 2015 This report studies ... over the forecast period of 2014 to 2019. ... CAGR of 6.5% from 2014 to 2019. , ... this report, the global pharmacovigilance and drug safety ... on the basis of functionality, namely, adverse event ...
(Date:3/30/2015)... 2015 On March 19th, 2015, in ... of the Detroit Lions, LiveToBeSober.org hosted the “Fighting Addiction ... ministers and bishops as well as other civic leaders ... at the luncheon, including retired Detroit Lions wide receiver ... and two survivors of their own personal battles with ...
(Date:3/30/2015)... Dr. Shahdad Arami is now ... receive $200 off their Invisalign treatment. Many people crave ... a mouthful of metal. Invisalign offers an alternative. According ... is effective for straightening teeth but has no aesthetic ... oral appearance. The Invisalign system allows both teenagers and ...
Breaking Medicine News(10 mins):Health News:Jiwa Law Corporation States That Majority of Their Cases Get Settled Before Trial 2Health News:The Global Tumor Ablation Market is Poised to Reach the Value of $462.0 Million in 2019 - MarketsandMarkets Released Recently 2Health News:The Global Tumor Ablation Market is Poised to Reach the Value of $462.0 Million in 2019 - MarketsandMarkets Released Recently 3Health News:The Global Pharmacovigilance and Drug Safety Software Market is Poised to reach the Value of $154.1 Million in 2019 - Report by MarketsandMarkets 2Health News:The Global Pharmacovigilance and Drug Safety Software Market is Poised to reach the Value of $154.1 Million in 2019 - Report by MarketsandMarkets 3Health News:The Global Pharmacovigilance and Drug Safety Software Market is Poised to reach the Value of $154.1 Million in 2019 - Report by MarketsandMarkets 4Health News:LiveToBeSober.org Releases Highlight Reel of Substance Abuse Conference Keynote Speakers 2Health News:Northridge Cosmetic Dentist, Dr. Arami, is Now Offering a New Promotion on Invisalign 2
(Date:3/30/2015)... YORK , March 30, 2015 ... based nurse call systems," announced the high level ... with the ClinicAll infotainment systems. The ... on patient entertainment terminals; this allows patients to ... on their need and acuity. The advanced functionality ...
(Date:3/30/2015)... CUPERTINO, Calif. , March 30, 2015 /PRNewswire/ ... announced that it has initiated a multi-dose Phase ... DUR-928, the lead molecule in DURECT,s Epigenomic Regulator ... entity (NCE) that may have broad applicability in ... (NAFLD) and nonalcoholic steatohepatitis (NASH).  It may also ...
(Date:3/30/2015)... 30, 2015  BioPharmX Corporation (OTCQB: BPMX), a ... novel drug delivery products to address unmet needs ... the appointment of Stephen Morlock , a ... its board of directors.  Mr. Morlock,s background will ... its national roll-out of Violet iodine, the new, ...
Breaking Medicine Technology:NiQ Health Announces CarePlus(TM) Integration with ClinicAll 2DURECT Announces Initiation of DUR-928 Multi-Dose Phase 1 Study 2DURECT Announces Initiation of DUR-928 Multi-Dose Phase 1 Study 3DURECT Announces Initiation of DUR-928 Multi-Dose Phase 1 Study 4BioPharmX Corporation Appoints Stephen Morlock To Its Board Of Directors 2BioPharmX Corporation Appoints Stephen Morlock To Its Board Of Directors 3
Cached News: